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ABSTRACT

Poor maternal diet refers to either a nutritional excess or deficiency in the mother during
gestation (Reed et al. 2014). It has been well-studied that poor maternal gestational nutrition
limits bone and muscle development while increasing adipose development in the offspring
(Oreffo et al. 2003; Reed et al. 2014). There is also evidence that suggests poor maternal diet
during gestation impairs mesenchymal stem cell (MSC) function (Oreffo et al. 2003). Tissues
including bone, muscle, and adipose are derived from this fetal MSC pool (Lawrence et al.
2012). It was hypothesized that poor maternal diet during gestation would negatively alter MSC
metabolism in offspring. Eighteen ewes were bred, confirmed pregnant, and individually housed.
At d 31  1.3 of gestation, ewes were randomly assigned to one of three diets: 100% (CON),
60% (RES), or 140% (OVER) of NRC requirements for TDN. The diet was maintained until
parturition, after which one lamb per ewe was euthanized within 24 h. MSC (n = 6/treatment
group) were isolated from the left tibia and femur of the lamb. Cells were plated at 30,000
cells/well and incubated for 48 h at 37oC. Glycolytic and mitochondrial function of the MSC
were evaluated using Glycolysis Stress and Cell Mito Stress Test Kits. The assays were
performed in the Seahorse XFe24 Extracellular Flux Analyzer. Data were normalized for total
cellular DNA content and statistical analysis was performed using PROC MIXED in SAS. Basal
respiration was reduced in RES and OVER, compared with CON (127.4 ± 7.48, 90.17 ± 9.75,
and 87.51 ± 8.48 ρmol O2-1·minute-1·μg; CON, RES, and OVER, respectively; P ≤ 0.008).
Compared with CON, RES and OVER had reduced ATP production (121.09 ± 6.08, 84.86 ±
11.05, and 77.7 ± 6.44 ρmol O2-1·minute-1·μg; CON, RES, and OVER, respectively; P ≤ 0.006)
and reduced maximal respiration (149.29 ± 17.05, 90.64 ± 23.81, and 67.93 ± 10.15 ρmol O2-
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·minute-1·μg; CON, RES, and OVER, respectively; P ≤ 0.03). Spare respiratory capacity was

reduced in OVER compared with CON (P = 0.02) while RES were intermediate (21.9 ± 10.8,
0.47 ± 12.3, and -19.56 ± 9.24 ρmol O2-1·minute-1·μg; CON, RES, and OVER, respectively; P ≤
0.25). There were no significant differences between groups for proton leak, non-mito-derived
OCR, coupling efficiency, glycolysis, glycolytic reserve, non-glucose-derived extracellular
acidification rate, and glycolytic reserve capacity (P ≥ 0.18). In conclusion, poor maternal diet
during gestation reduces the basal metabolic state of MSC and restricts the ability to produce
ATP during energetic demands. This could possibly contribute to the observed differences in
muscle, bone, and adipose development of offspring born to over-fed or under-fed mothers.

5

INTRODUCTION

It is becoming increasingly difficult to meet the worldwide food demand, with a human
population of 7 billion in 2012 and 9 billion people expected by 2050 (Vonnahme et al., 2015).
Food production industries must consider not only the supply, but also the efficiency of food
animal production. However, several production practices that aim to maximize efficiency
inadvertently compromise the quality of fetal growth, often through an inadequate maternal diet
(Vonnahme et al., 2015). Poor maternal nutrition refers to either an excess or lack of nutrition
during gestation, which can be due to overall nutrients or specific nutrients in the diet (Reed et
al., 2014). Maternal over nutrition, such as ‘flushing’, can negatively affect fetal health (Wu et
al., 2006). For example, over nutrition in the sow during ovulation increases fetal mortality and
over nutrition in both the sow and ewe during ovulation reduces fetal growth (Wu et al., 2006).
On the contrary, maternal under nutrition can result from the breeding of immature animals or
pasture grazing, and can be detrimental to fetal growth (Wu et al., 2006). This paper will discuss
the importance of mesenchymal stem cells (MSC) in the development of bone, muscle, and fat
and the effects of poor maternal nutrition on these tissues in the offspring. The effects of poor
maternal nutrition on fetal growth are well documented, but the mechanisms are poorly
understood. Therefore, the objective of this literature review is to consider several mechanisms
connecting poor maternal nutrition to poor fetal growth. Current research focuses on the role of
fetal metabolic programming and altered mitochondrial function as possible mechanisms. The
metabolism of MSC is an important area of focus because there are several nutrient-sensing
pathways that control metabolic status (Agathocleous et al., 2013; Ochocki et al., 2013; Ito et al.,
2014). Additionally, the relative ratios of glycolytic and mitochondrial ATP production shift as
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MSC differentiate into bone, muscle, and adipose (Shyh-Chang et al., 2013). Fetal metabolism
can also be programmed during certain in utero conditions, including poor maternal diet (Wu et
al., 2006; Fernandez-Twinn et al., 2010). This metabolic programming, specifically of MSC, is a
possible mechanism by which poor gestational maternal diet leads to poor fetal growth and
development
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REVIEW OF LITERATURE

Mesenchymal Stem Cells
Establishment
Mammals are comprised of many different cell types that differ in both morphology and
physiology in order to fulfill the specific roles of that tissue. Stem cells are the original,
embryonic cells that differentiate into every cell type (Lawrence et al., 2012). Initially,
embryonic cells are totipotent, being able to differentiate into any cell type of an adult organism
(Lawrence et al., 2012). At the blastocyst stage, the stem cells are considered pluripotent, being
able to form only one of two cell types – the epithelium or the mesenchyme (Lawrence et al.,
2012). The mesenchymal cells can differentiate into several different cell types; however, the
focus of this discussion will be on the formation of muscle, bone, and fat due to the importance
of these tissues in food animal production (Lawrence et al., 2012).

Differentiation of MSC into Bone, Muscle, and Adipose Tissues
Endochondrial ossification involves the replacement of a cartilage model with bone
(Lawrence et al., 2012). Mesenchymal stem cells first condense, and then differentiate into
chondroblasts, followed by differentiation into chondrocytes and extracellular matrix secretion
(Lawrence et al., 2012). This primordial cartilage template is replaced with bone through
vascularization, calcification, and the replacement of chondroblasts with osteoblasts (Lawrence
et al., 2012). Mesenchymal stem cells can also differentiate into an entirely different tissue type,
muscle.
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Muscle development can be divided into three distinct stages: embryonic, fetal, and
postnatal. During embryonic muscle development, MSC differentiate into primary myoblasts
(Lawrence et al., 2012). Following proliferation, myoblasts fuse to form primary myotubes and
develop the protein scaffolding characteristic of mature myofibers (Lawrence et al., 2012).
During fetal muscle development, MSC differentiate into secondary myoblasts, followed by
secondary myotubes, and ultimately into secondary myofibers (Lawrence et al., 2012). Postnatal
muscle development involves muscle cell replacement in response to injury, muscle fiber
hypertrophy, and protein accretion (Lawrence et al., 2012). Muscle cell progenitor cells, known
as satellite cells, are quiescent along the periphery of the muscle fiber (Lawrence et al., 2012).
Muscle injury signals these satellite cells to differentiate, in a process very similar to primary
myogenesis (Lawrence et al., 2012). Mesenchymal stem cells also develop into adipose tissue.

Adipose development can be divided into two phases: prenatal and postnatal. Prior to
birth, epigenetic hypomethylation and adipogenic transcription factors signal MSC to
differentiate into pre-adipocytes, followed by adipocytes (Lawrence et al., 2012). Unable to
proliferate, adipocyte numbers can only increase through the proliferation/differentiation of
either MSC or pre-adipocytes (Lawrence et al., 2012). Postnatal adipose development can also
occur through lipid droplet accumulation within the adipocyte (Lawrence et al., 2012). Although
MSC are predominantly involved in embryogenesis, MSC stores remain in several tissues in the
adult organism.

Roles in the Adult
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Mesenchymal stem cells can be found in several adult tissues, including bone marrow,
adipose, umbilical cord blood, pancreas, and synovial tissue (Ramalingam et al., 2012).
However, only bone marrow, and adipose to a lesser extent, contains significant numbers of
MSC (Ramalingam et al., 2012). These MSC remain quiescent in the body, but can be signaled
to differentiate into new tissue cells during times of cell injury and to proliferate in order to
maintain MSC numbers (Ramalingam et al., 2012). However, the function of MSC can be
influenced by several factors, including the quality of maternal diet in utero.

Poor Maternal Nutrition
Effects on Mesenchymal Stem Cells
The health of fetal MSC is affected by the quality of fetal nourishment provided through
the maternal diet (Oreffo et al., 2003). For example, maternal protein restriction was found to
delay the normal proliferation and differentiation of MSC (Oreffo et al., 2003). In addition, fetal
stem cells from low-protein maternal diets displayed a phenomenon called ‘catch-up growth’, in
which a tissue initially of low proliferative ability (due to nutrient restriction in utero) eventually
surpasses the proliferative ability of the control (Oreffo et al., 2003). Oreffo et al. (2003)
evaluated this phenomenon using total colony forming unit-fibroblastic (CFU-F) colony number,
a measure of the ability of MSC to proliferate and form colonies. Total CFU-F numbers of lowprotein diet MSC were decreased by 40% at eights weeks, not different at twelve weeks, and
increased by 111% at sixteen weeks of fetal age in rats (Oreffo et al., 2003). These differences
seen in MSC of poorly nourished mothers can potentially lead to the effects of poor maternal
nutrition on bone, muscle, and adipose development.
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Effects on Bone, Muscle, and Adipose Development
Bone forms the structural support of the animal, stores excess nutrients, and acts as a
reserve of several important cell types, such as red blood cells and stem cells (Lawrence et al.,
2012). However, bone development can be affected by the fetus’s perinatal environment,
including maternal nutrition. Previous studies have demonstrated that poor maternal diet
predisposes the offspring to decreased bone density in rats (Oreffo et al., 2003). Similarly,
Lanham et al. (2010) found that mice from dams fed a high-fat diet during gestation had both
decreased bone mineral content and density, compared with control. Furthermore, rodent studies
demonstrate that low-protein maternal diets reduce bone mineral content, bone area, and alter
growth plate appearance in offspring (Oreffo et al., 2003; Lanham et al., 2010). Interestingly,
offspring from dams fed a high-fat diet during gestation experienced an increase in bone crosssectional area, yet further investigation attributed this to increased lumen area as opposed to
increased wall thickness (Lanham et al., 2010). This suggests that the bone is more prone to
fracture (Oreffo et al., 2003). The offspring from dams fed a high-fat gestational diet also
experienced reduced femur length and increased bone marrow adiposity (Lanham et al., 2010).
Both low-protein and high-fat gestational diets were shown to restrict osteoblast differentiation
and arrest the differentiation of recruited marrow stromal cells (Oreffo et al., 2003; Lanham et
al., 2010). The development of bone, muscle, and adipose is closely interconnected due to the
common MSC origin.

Muscle development can be affected through several ways, such as altered muscle fiber
number (determined prenatally) and altered postnatal muscle characteristics, which include fiber
type, protein accretion, and fiber size (Lawrence et al., 2012). A study conducted by Reed et al.
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(2014) found that maternal over- and under-nutrition during gestation increased cross-sectional
area (CSA) of the lamb’s semitendinosus muscle at one day of age, but decreased this CSA at
three months of age. Additionally, the proportion of muscle fiber types is a major determinate of
postnatal growth and is also related to oxidative capacity, insulin sensitivity, and meat quality
(Wu et al., 2006; Reed et al., 2014). In pigs, researchers found that lower-weight piglets had
more oxidative and fast-oxidative fibers and less glycolytic fibers, as compared with heavier
piglets (Wu et al., 2006). Similarly, lambs of over- and under-fed ewes exhibited an increase in
oxidative Type IIa and decrease in glycolytic Type I muscle fibers, compared with control (Reed
et al., 2014). Oxidative fibers contract slower than glycolytic fibers, and rely more on oxidative
mitochondrial function for energy production (Lawrence et al., 2012). Therefore, this increased
proportion of oxidative muscle fibers is associated with increased reliance on mitochondrial
function and ATP production. These studies demonstrate that (1) fetal muscle fiber type is
influenced by maternal diet and (2) the proportion of fiber types predisposes the fetus to a certain
type of growth and body type (Wu et al., 2006; Reed et al., 2014). Due to the common MSC
origin, it is also important to consider adipose development when considering bone and muscle
development.

Adipose is one of the last tissues to develop, given priority behind that of bone and
muscle (Lawrence et al., 2012). However, poor maternal diet can alter the priority given to the
development of these tissues. When myogenesis is restricted, adipose deposition is given priority
over muscle development (Wu et al., 2006). Reed et al. (2014) found that lipid content in
semitendinosus muscle of one-day-old lambs was 212.4% and 92.5% greater from overfed and
underfed ewes, respectively, compared with control. Yet, at three months of age, lambs from
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overfed ewes had 36.1% greater lipid content while those from underfed ewes had 23.6% less
lipid content, compared with control (Reed et al., 2014). These changes can alter not only fetal
physiology, but are also undesirable for meat quality. Studies show that at slaughter, animals
with increased intramuscular fat exhibit increased lipid peroxidation, which oxidizes muscle (Wu
et al., 2006). This results in tougher meat and a reduction in the bright color of red meats (Wu et
al., 2006). The close relationship between bone, muscle, and adipose tissues is due to the fact
that each tissue is originally derived from the mesenchyme stem cell layer (Lawrence et al.,
2012). In addition to effects of these specific tissues, poor maternal diet during gestation can
alter whole body fetal physiology.

Effects on Whole Body Function
The effects of poor maternal nutrition include reduced survival rates, stunted growth,
altered whole body composition, poor meat quality, and permanent changes in health of the
offspring (Wu et al., 2006). In sheep, studies have shown poor maternal diet can lead to several
fetal metabolic dysfunctions, including insulin resistance, obesity, oxidative stress, and
mitochondrial dysfunction (Wu et al., 2006). These offspring showed improved, but not
corrected, growth when supplemented with energy, protein, concentrates, or both (Wu et al.,
2006). Due to the permanent changes in fetal physiology, fetal programming is one proposed
mechanism for the effects exerted by poor gestational diet on fetal growth and development.

Fetal Programming and Maternal Diet
Fetal growth is a complex process that is influenced by many different internal and
external factors, including genetics, epigenetics, and the environment (Wu et al., 2006).
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However, recent research has emphasized the importance of the offspring’s intrauterine and
perinatal environments in determining lifelong health status, which were originally not given
sufficient consideration (Tamashiro et al., 2010). The term ‘fetal programming’ refers to
permanent changes in the expression of the fetal genome as a result of the fetal environment (Wu
et al., 2006; Fernandez-Twinn et al., 2010). Barker and Hales proposed that ‘fetal metabolic
programming’ is a risk factor for the development of several chronic metabolic disorders (Hales
et al., 2013). These programming events are believed to be the result of epigenetic modifications
to the offspring’s genome (Hales et al., 2013). Lanham et al. (2010) notes how organisms
experience developmental plasticity, or the ability to alter development based on a certain
environment. Developmental plasticity is possible due to epigenetics and the regulation of gene
expression (Lanham et al., 2010). Epigenetics refers to posttranslational DNA alterations that
regulate gene expression without changing the actual DNA sequence, and includes DNA
methylation, genomic imprinting, and chromatin remodeling (Tamashiro et al., 2010). One of the
environmental factors that influences fetal programming is maternal/fetal nutrition (Wu et al.,
2006; Tamashiro, et al., 2010). The ‘developmental origins of health and disease’ hypothesis
suggests that some chronic diseases can be attributed to the early life environment (Lanham et
al., 2010). There are several very similar hypotheses concerning maternal nutrition and fetal
programming with a common theme: maternal diet influences fetal health through programming
mechanisms.

The ‘predictive adaptive response’ refers to programmed changes in a fetus’s phenotype
suited to be advantageous to a certain type of environment (Lanham et al., 2010). Fetal
programming is a mechanism that prepares the fetus for birth into this specific environment
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(either lack of nutrients or surplus of nutrients); a mismatch between perinatal and postnatal
environments results in an altered physiological state, such as fetal metabolic up regulation
(Igosheva et al., 2010; Chiaratti et al., 2015). This phenomenon has been referred to as a two-hit
process (Tamashiro et al., 2010). The “first hit” is a result of poor in utero conditions that
promote fetal programming (Tamashiro et al., 2010). However, Tamashiro et al. (2010) suggests
that this poor maternal environment is not the direct cause of chronic disorders characteristic of
the ‘developmental origins of health and disease’ hypothesis. Rather, the “first hit” increases the
offspring’s susceptibility to a “second hit”, which is a postnatal challenge that cannot be
appropriately met by a “first hit” offspring, resulting in a diseased state (Tamashiro et al., 2010).
The postulates of the “thrifty phenotype hypothesis” echo those of the “predictive adaptive
response”.

The “thrifty phenotype hypothesis” suggests that offspring of nutrient-restricted mothers
develop certain metabolic disorders as a result of programming in utero (Tamashiro et al., 2010).
During development, the nutrient-restricted perinatal environment programs the offspring for
birth into an equally nutrient-restricted, or thrifty, environment (Tamashiro et al., 2010). For
example, malnutrition in utero can cause metabolic and physiological changes that prioritize
nutrients towards the most vital organs, at the expense of other organs, in order to maximize
chances of survival in a nutrient-restricted environment (Fernandez-Twinn et al., 2010).
However, this programming negatively affects the offspring when it experiences an energy
balance challenge, such as an unexpected abundance of nutrients (Fernandez-Twinn et al., 2010;
Tamashiro et al., 2010). Therefore, perinatal conditions are as equally important as postnatal
conditions, especially the mismatch between the two. For example, glucose tolerances were

15

worst in individuals that were born small and developed obesity with age, and therefore
experienced a drastic change in perinatal and postnatal environments (Fernandez-Twinn et al.,
2010). Similarly, an animal can experience drastic physiological change when they undergo
“catch-up growth”, as previously described (Fernandez-Twinn et al., 2010).

Catch-up growth refers to an unexpected increase in a tissue’s proliferative ability
following its initial slow growth and development (Oreffo et al., 2003; Fernandez-Twinn et al.,
2010). However, catch-up growth is not considered a corrective mechanism; rather, it introduces
a host of health concerns, as demonstrated by Fernandez-Twinn et al. (2010) study. Offspring
from a dam fed an 8% low-protein diet weighed 15% less than control, at birth (FernandezTwinn et al., 2010). However, the lower weight rats experienced rapid catch-up growth during
lactation, and were referred to subsequently as “recuperated” (Fernandez-Twinn et al., 2010).
Despite regaining this initial stunted growth, the life span of the “recuperated” male rats was
reduced by 25%, attributable mostly to kidney failure (Fernandez-Twinn et al., 2010). On the
contrary, rats that were carried in utero by a dam fed a 20% normal protein diet and suckled by a
dam fed an 8% low-protein diet dam did not suffer the effects of catch-up growth, specifically
reduced longevity (Fernandez-Twinn et al., 2010). Therefore, catch-up growth appears to be a
programming mechanism that results from nutrient inadequacies in utero. One of common fetal
mechanisms susceptible to in utero programming is metabolic physiology (Chiaratti et al., 2015).

Changes in fetal metabolic physiology in response to maternal diet can also be referred to
as stress-induced metabolic programming (Chiaratti et al., 2015). For example, the least
successful mouse litters (defined as low litter fetal weight, low litter placental weight, and low
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litter size) had the highest levels of placental mitochondrial DNA (mtDNA); (Chiaratti et al.,
2015). The researchers found that mice from protein-restricted mothers contained greater
amounts of placental ATP (Chiaratti et al., 2015). These results suggest that fetal metabolism is
influenced by maternal diet. Other researchers similarly note links between maternal obesity,
increased mitochondrial potential, and increased mtDNA content (Igosheva et al., 2010). These
changes in fetal metabolic physiology, possibly due to maternal programming, result in whole
body fetal metabolic changes: increase in reactive oxidative species, decrease in glutathione (the
principle cellular anti-oxidant), more oxidized redox state, clustered mitochondrial distribution,
and increased mtDNA copy number in the oocyte, which all suggest metabolic up-regulation
(Igosheva et al., 2010; Ochocki et al., 2013). However, the “quiet embryo hypothesis” suggests
that low levels of metabolism promote embryo survival before implantation (Chiaratti et al.,
2015). Therefore, altered fetal metabolism could be one of the mechanisms explaining poor fetal
growth as a result of poor maternal diet, and will be the focus of the remainder of this literature
review.

Metabolism
Normal Metabolic Physiology
Cells can obtain energy through one of two processes: anaerobic glycolysis or oxidative
phosphorylation (OXPHOS); (Ochocki et al., 2013). Glycolysis can produce ATP at a much
faster rate than OXPHOS, but can only produce a net two ATP molecules per molecule of
glucose (Ochocki et al., 2013). On the contrary, OXPHOS metabolizes its substrates more
completely in order to produce a net 36 to 38 ATP molecules per molecule of glucose (Ochocki
et al., 2013). This is accomplished through the oxygen-demanding electron transport chain,
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during which the transfer of electrons between five complexes catalyzes the phosphorylation of
ADP to ATP (Bhat et al., 2015). To meet energetic demands, most mature cells rely on
OXPHOS over glycolysis (Igosheva et al., 2010; Bhat et al., 2015). However, a cell’s metabolic
status changes throughout the differentiation process.

Cell Differentiation Status and Metabolic Preference
Metabolism is unique in that it is fairly plastic; a cell’s metabolic profile evolves with
cellular differentiation (Burgess et al., 2014). This property allows the metabolic physiology to
suit the cell’s needs at different developmental stages and in different cell types (Agathocleous et
al., 2013; Burgess et al., 2014). For example, metabolism is a key determinant of whether a cell
proliferates, differentiates, or remains quiescent (Shyh-Chang et al., 2013). In addition, stem
cells are influenced by the local microenvironment, known as a stem cell niche, in order to
maintain quiescence (Ito et al., 2014). Bone marrow-derived MSC (BMSC) are suited for a lowoxygen, hypoxic niche; this hypoxic niche promotes maintenance of the undifferentiated state,
and also favors glycolysis over OXPHOS (Ito et al., 2014). In general, undifferentiated cells
prefer anaerobic glycolysis to meet energy demands, while differentiated cells switch to
OXPHOS for ATP production (Burgess et al., 2014; Ito et al., 2014). This change represents a
cell’s physiological evolution as it undergoes differentiation.

The totipotent stem cells of the pre-blastocyst embryo are the least differentiated cells
and initially have low glycolysis rates; the glycolytic enzymes hexokinase (HK) and
phosphofructokinase 1 (PFK1) are rate limiting and limit glycolysis rates (Shyh-Chang et al.,
2013). Energy and carbon sources are derived from analogs of pyruvate, until the embryo
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reaches the morula stage and glucose oxidation rivals that of pyruvate (Shyh-Chang et al., 2013).
Mitochondrial structure is not yet mature, and therefore oxygen consumption rates are generally
low (Shyh-Chang et al., 2013). Prior to blastocyst implantation, the number of mitochondria
halves with each cell division, and therefore ATP levels and ATP/ADP ratio decrease with time
(Shyh-Chang et al., 2013). ATP levels inhibit PFK1, and therefore this ATP decrease may
contribute to the activation of glycolysis at the successive differentiation stage (Shyh-Chang et
al., 2013).

Pluripotent stem cells of the blastocyst become more metabolically active. To meet needs
for rapid growth, glucose uptake increases due to up-regulated expression of glucose transporters
GLUT1 and GLUT3 (Shyh-Chang et al., 2013). Although rates of OXPHOS increase, glycolysis
is still the preferred metabolic status of pluripotent stem cells (Shyh-Chang et al., 2013).
Interestingly, the generation of induced pluripotent stem cells (iPSCs), which are somatic cells
reprogrammed to be pluripotent, initiates a switch from OXPHOS to glycolysis that precedes the
presence of pluripotency markers (Shyh-Chang et al., 2013). This suggests that glycolysis is not
specific to pluripotency but rather an ideal metabolic state for cells of rapid proliferative ability
(Shyh-Chang et al., 2013). Therefore, the ratio of glycolysis to OXPHOS is expected to decrease
with increasing differentiation.

Once embryonic stem cells begin differentiation, proliferation slows and cells switch
from glycolysis to OXPHOS to meet energetic demands (Shyh-Chang et al., 2013). This switch
is partly influenced by the electron transport chain (ETC) re-coupling with ATP synthase, which
triggers a sharp increase in oxygen consumption (Shyh-Chang et al., 2013). The coupling
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between glycolysis and the Krebs cycle also strengthens (Shyh-Chang et al., 2013). OXPHOS,
and specifically the ETC, increase the production of reactive oxidative species (ROS), which
promote cellular differentiation under low ROS levels (Shyh-Chang et al., 2013).

Cell types that remain undifferentiated and quiescent in adult tissues, such as MSC,
prefer a slow-cycling state (Shyh-Chang et al., 2013). Evidence includes higher expression of
glycolytic enzymes and lower expression of OXPHOS proteins (Shyh-Chang et al., 2013). In an
undifferentiated bone marrow MSC, glycolysis accounts for about 97% of ATP production while
glucose and fatty acid oxidation only account for about 3% (Fillmore et al., 2015). It is believed
that MSC prefer this glycolytic state in order to minimize damaging ROS and preserve selfrenewal abilities (Shyh-Chang et al., 2013). This is supported by the fact that MSC cultured in
normoxia conditions have enhanced proliferative ability yet also experienced increased
senescence (Agathocleous et al., 2013; Shyh-Chang et al., 2013; Ito et al., 2014). MSC must
maintain their self-renewal capability in order to act as a reserve for adipocytes, osteoblasts, and
chondroblasts. In addition, proliferative ability is enhanced by glycolysis, which maintains high
rates of macromolecular synthesis (Fillmore et al., 2015). Finally, it appears that cell fate is
partially determined by shifts in MSC metabolic status. Differentiation of MSC to pre-adipocytes
occurs under conditions of high OXPHOS, high ROS, and high oxygen (Shyh-Chang et al.,
2013). However, differentiation towards osteoblast lineage is characterized by conditions of high
OXPHOS, low ROS, and high oxygen (Shyh-Chang et al., 2013). On the contrary, chondroblast
differentiation prefers low OXPHOS and high glycolysis levels (Shyh-Chang et al., 2013). In
addition to differentiation status, several environmental-sensing pathways also influence a cell’s
metabolic profile.
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Regulation of Metabolic State: Role of Oxygen and Nutrient Sensing Pathways
Hypoxia-inducible factors (HIF) are transcription factors that regulate the glycolysis to
OXPHOS ratio through sensing of environmental O2 conditions (Agathocleous et al., 2013;
Burgess et al., 2014). HIF plays a critical role in the homeostasis of stem cells (Ochocki et al.,
2013). HIF1 is a protein that consists of two different subunits: the HIF-1 subunit is responsive
to hypoxic conditions while the HIF-1 subunit is constitutively expressed (Ito et al., 2014).
During low O2 conditions (hypoxia), HIF-1 is critical for the switch from OXPHOS to
glycolysis (Agathocleous et al., 2013; Burgess et al., 2014). HIF-1 promotes the expression of
pyruvate dehydrogenase kinase (PDK) isoforms 2 and 4, which are responsible for the
phosphorylation of pyruvate dehydrogenase (PDH) and subsequent inhibition of pyruvate entry
into the TCA cycle (Ochocki et al., 2013; Ito et al., 2014). HIF-1 is degraded under normoxic
conditions, leading to decreased HIF1 levels (Agathocleous et al., 2013; Ito et al., 2014). HIF-1
expression is higher in less differentiated cells, which suggests one possible mechanism by
which stem cells maintain their preference for glycolysis (Burgess et al., 2014). Other
mechanisms for metabolic regulation include nutrient-sensing pathways.

The P13K-AKT-mTOR pathway is a nutrient-sensing pathway that promotes cellular
proliferation under the regulation of both growth factors and nutrients, like glucose and amino
acids (Ito et al., 2014). Mammalian target of rapamycin (mTOR) is a kinase that senses oxygen,
nutrients, and growth factors through the P13K-AKT pathway (Ochocki et al., 2013). There are
two distinct complexes: mTORC1 and mTORC2 (Ochocki et al., 2013). mTOR increases the
number of mitochondria, and therefore up-regulates metabolism (Shyh-Chang et al., 2013). Upon
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stimulation of nutrients or amino acids, mTORC1 is activated and phosphorylates its targets to
stimulate mRNA translation, glycolysis, and lipid/nucleotide synthesis (Agathocleous et al.,
2013; Ochocki et al., 2013). Overall, the P13K pathway negatively affects stem cell function by
initiating stem cell aging, quiescence, and stem cell exhaustion (Ito et al., 2014). Therefore, the
P13K pathway may have significant effects in the offspring of over-fed mothers. In addition,
mTOR is inhibited by AMPK, which provides a bridge between the P12K-AKT-mTOR and
LKB1-AMPK pathways (Agathocleous et al., 2013).

The LKB1-AMPK is another nutrient-sensitive pathway that affects metabolic
physiology (Ito et al., 2014). AMP-activated protein kinase (AMPK) is an  heterotrimeric
enzyme that is considered the master regulator of metabolism (Ochocki et al., 2013). The tumor
suppressor liver kinase B1 (LKB1) is a serine/threonine kinase that is believed to limit cell
growth when poor energetic conditions are sensed (Agathocleous et al., 2013; Ito et al., 2014).
Under low energy conditions, the AMP/ATP ratio increases and LKB1 phosphorylates/activates
AMPK (Ochocki et al., 2013; Ito et al., 2014). AMPK inhibits mTORC1, resulting in reduced
proliferation, inhibition of anabolic pathways such as lipogenesis and protein synthesis, and
activation of catabolic pathways such as fatty acid oxidation and glucose uptake (Agathocleous
et al., 2013; Ochocki et al., 2013; Ito et al., 2014). Therefore, the P13K and AMPK pathways act
in contrast to each other. With restricted cellular proliferation, stem cell longevity is extended
through decreased cellular aging, quiescence, and stem cell exhaustion (Ito et al., 2014). This
AMPK pathway is of special interest for offspring of under-fed mothers. Metabolic regulation
through these pathways is important because sensitive stem cells must compromise the efficiency
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of oxygen-derived OXPHOS with the production of potentially harmful reactive oxidative
species (Agathocleous et al., 2013; Shyh-Chang et al., 2013; Ito et al., 2014).

Reactive Oxidative Species: Physiological and Pathological Levels
Reactive oxidative species (ROS) are normal byproducts of aerobic energy production.
The substrates needed for the ETC, such as NADH, are produced during the citric acid cycle
(Igosheva et al., 2010). Nicotinamide adenine dinucleotide (NAD) is one important control
mechanism for redox state (Ochocki et al., 2013). NAD is an electron-transferring molecule in
redox reactions; it can accept electrons to become the reduced NADH species or donate electrons
to become the oxidized NAD+ state (Ochocki et al., 2013). The NAD+/NADH ratio is a valuable
measurement of a cell’s redox status (Ochocki et al., 2013). NADH is oxidized in the ETC,
resulting in several changes: (1) an increase in ROS and (2) a decrease in peroxiredoxins,
thioredoxin, and oxidized glutathione (Igosheva et al., 2010). In addition, 1 to 5% of the oxygen
consumed during oxidative phosphorylation is converted to ROS (Bhat et al., 2015). Normally,
complex III of the electron transport chain is the main production center of ROS (Bhat et al.,
2015). Although harmful in high concentrations, low concentrations of ROS are needed for
several important cellular functions and therefore ROS is considered a physiological molecule
(Ochocki et al., 2013).

Low physiological ROS levels have one of two functions: (1) activate DNA repair
mechanisms, or (2) promote cellular differentiation (Ochocki et al., 2013). Inhibition of ROS
production negatively affects cell function. For example, exogenously added antioxidants (such
as hydrogen peroxide) counteract ROS and cause early MSC senescence (Lyublinskaya et al.,
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2015). Further, it has been demonstrated that this antioxidant treatment blocks the G1-S transition
of MSC cell cycle (Lyublinskaya et al., 2015). In fact, there is a positive and linear relationship
between the number of cells in S phase and the concentration of ROS (Lyublinskaya et al.,
2015). In addition, studies have demonstrated a positive correlation between cell proliferation
and ROS levels (Lyublinskaya et al., 2015). Therefore, physiologic levels of ROS exert some
control over the cell cycle. However, abnormally high levels of ROS pose several health risks,
such as oxidative stress (Bhat et al., 2015).

Oxidative stress is defined as the detrimental overproduction of ROS and nitrosative
stress as the overproduction of reactive nitrogen species (RNS); (Bhat et al., 2015). Oxidative
stress presents a concern during pregnancy because both maternal and fetal metabolisms are
performing at their highest rates during gestation (Wu et al., 2006). Therefore, pregnancy is
characterized by increasing levels of oxidizing agents, such as the superoxide anion, hydrogen
peroxide, lipid peroxide, and hydroxyl radicals (Wu et al., 2006). Both ROS and RNS, in excess
concentrations, can injure cells due to their free radical nature (Bhat et al., 2015). A free radical
is a molecule with one or more unpaired electrons (Bhat et al., 2015). Free radicals are very
reactive and can therefore stimulate inappropriate reactions with cellular components (Bhat et al.,
2015). The consensus among current studies is that ROS targets the integrity of DNA,
particularly mtDNA (Igosheva et al., 2010; Estrada et al., 2012). While ROS are necessary for
normal cell physiology, it must be controlled in order to prevent detrimental oxidative stress. The
processes that create a balance between healthy and unhealthy concentrations of ROS comprise
the term “Redox Regulation” (Bhat et al., 2015).
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Forkhead O (FOXO) transcription factors are one control mechanism for ROS production
(Ochocki et al., 2013; Burgess et al., 2014). FOXO transcription factors work by both preventing
ROS production, through the increased expression of antioxidant enzymes, and correcting ROSinduced damage, by activating DNA repair enzymes (Ochocki et al., 2013; Burgess et al., 2014;
Ito et al., 2014). Of the FOXO family, FOXO3 is particularly important for ROS control because
it regulates the expression of manganese superoxide dismutase (Ochocki et al., 2013; Burgess et
al., 2014). In addition, FOXO transcription factors regulate the cell cycle and apoptosis, and
therefore play a major role in both proliferation and longevity (Ochocki et al., 2013). The FOXO
transcription factors are positively regulated by the AMP kinase (AMPK) and negatively
regulated by the P13K signaling pathways (Ochocki et al., 2013; Ito et al., 2014). Therefore, a
deficiency in FOXO transcription factors can restrict the oxidative stress response, which is
crucial to preserving cellular health (Shyh-Chang et al., 2013). Another source of ROS regulation
is the ataxia telangiectasia mutated (ATM) pathway (Ito et al., 2014). The ATM protein is a
kinase that is required for DNA repair in times of damaging oxidative stress (Ito et al., 2014).
When these control mechanisms fail, and ROS levels become pathological, altered metabolic
function becomes a concern.

Altered Metabolic Physiology
Research has focused on how maternal diet influences fetal metabolic function (Wu et al.,
2006; Igosheva et al., 2010). It was already known that obesity is a form of chronic low-level
inflammation characterized by increased levels of oxidative stress (Gallardo et al., 2015).
However, researchers discovered that this state is also transmissible to future generations
(Gallardo et al., 2015). Obese women had increased levels of ROS in their oocytes/zygotes and
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increased levels of oxidative stress during early gestation (Gallardo et al., 2015). In addition,
researchers evaluated the presence of two oxidative stress markers, malondialdehyde (MDA) and
nitric oxide (NO), in fetal blood. They found that both MDA and NO levels increased with
increasing maternal body mass index (BMI); (Gallardo et al., 2015). Gallardo et al. (2015)
proposes that since obesity is an inflammatory state, oxidant compounds (such as ROS) can cross
the placental barrier and promote oxidative stress in the fetus.

Both maternal over- and under-nutrition can affect the fetal redox regulation system (Wu
et al., 2006). For example, children born to obese mothers have an increased risk of developing
metabolic alterations, such as increased synthesis of proinflammatory adipocytokines, increased
risk of insulin resistance, and increased incidence of oxidative stress (Gallardo et al., 2015). It
was found that maternal nutrient restriction weakens the oxidative defense system by reducing
the amount of antioxidants (Wu et al., 2006). On the contrary, over nutrition allows for increased
oxidation of nutrients, resulting in increased ROS production (Wu et al., 2006). However, both
diets result in a more oxidized fetal metabolic state, which is prone to oxidative stress. In fact,
carbohydrates and fatty acids are known to be inducers of mitochondrial stress (Igosheva et al.,
2010). Therefore, it is important to consider the effects of maternal diet on fetal metabolic
physiology, specifically considering mitochondrial function.

Mitochondria are solely maternally inherited, and therefore the fetal metabolic state is
maternally influenced (Igosheva et al., 2010). Studies have already demonstrated that poor
maternal diet alters normal fetal metabolism (Gallardo et al., 2015; Igosheva et al., 2010; Wu et
al., 2006). However, it is unclear how excessive or limited metabolic function affects the whole
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fetus. Studies show that increased reliance on the electron transport chain increases the
production of ROS (Bhat et al., 2015). This mitochondrial overstimulation is often accompanied
with decreased antioxidant presence (Bhat et al., 2015). Combined, these metabolic alterations
create a vicious cycle. First, free radicals (such as ROS) attack the mtDNA structure, resulting in
a damaged complex I or III of the ETC (Bhat et al., 2015). This results in NADH depletion and
oxygen reduction (Bhat et al., 2015). The increased levels of ROS permit the secretion of
cytochrome C and Apoptosis Inducing Factor (AIF) from the inner mitochondrial membrane,
leading to apoptosis (Bhat et al., 2015). Apoptosis and the resulting oxidative stress lead to
cellular injury (Bhat et al., 2015). Therefore, these micro-scale effects of mitochondrial
dysfunction could, in part, result in the macro-scale, whole body fetal underdevelopment. In fact,
the normal process of aging is very similar to the described abnormal metabolic aging. The
“mitochondrial free radical theory of aging” states that aging results from: (1) cumulated mtDNA
mutations, (2) abnormal oxidative phosphorylation, (3) imbalance in antioxidant expression, and
(4) ROS overproduction (Bhat et al., 2015). The abnormal, environmentally influenced aging of
cells presents a challenge because it follows a mechanism of normal aging, yet occurs regardless
of animal age. Altered fetal metabolic physiology, and the subsequent premature cellular aging,
could be one mechanism by which poor maternal diet restricts fetal growth and development.

Conclusion
The food animal production industry is a vital component of both national employment
and the national economy. Therefore, maintaining animal health is essential to both maximizing
the efficiency of production and also meeting the ever-increasing food demand. To meet these
goals, researchers have considered how the quality of maternal diet affects fetal growth and
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development. Several conclusions have already been made: (1) MSC health is vital for proper
development of bone, muscle, and fat; (2) maternal diet influences the health of MSC, and
therefore growth of the fetus; (3) abnormal ROS levels play negative roles in the health of all
cells, especially MSC due to their sensitive stem cell nature; (4) current research suggests
correlations between ROS and maternal diet; and (5) altered metabolic regulation can present
lifelong complications in health status. Therefore, poor maternal diet and the subsequent poor
fetal growth/development could possibly be explained, in part, by diet-induced mitochondrial
dysfunction leading to ROS overproduction and the resulting oxidative stress. Research should
be continued in order to solidify this mechanism. Efficient growth and production of animals
requires normal and healthy MSC, which require proper maternal nutrition. It was hypothesized
that poor maternal diet during gestation would negatively alter mesenchymal stem cell
metabolism in offspring. Therefore, the objectives of this study included evaluating the
glycolytic and mitochondrial functions of MSC obtained from the lambs of ewes fed with a
CON, RES, or OVER diet during gestation.
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MATERIALS AND METHODS

Animals
All animal experiments were reviewed and approved by the University of Connecticut
Institutional Animal Care and Use Committee.

In a previous study, eighteen ewes were estrus synchronized with progesterone controlled
intravaginal drug release devices (Pfizer Animal Health, New York, NY) and Lutalyse (Zoetis,
Florham Park, New Jersey), followed by live-cover breeding to one of five rams (Reed et al.,
2014; Hoffman et al., 2016). On d 31  1.3 of gestation, individually-housed ewes were assigned
to one of three diets: 100%, 60%, or 140% of NRC (1992) requirements for TDN of ewes
carrying twins (Reed et al., 2014; Hoffman et al., 2016). Rations of complete pelleted feed
(Central Connecticut Farmer’s Co-Op, Manchester, CT) were calculated based on body weight,
weekly (Reed et al., 2014; Hoffman et al., 2016). Treatment diets were maintained until
parturition, after which lambs nursed colostrum for up to 24 h (Reed et al., 2014; Hoffman et al.,
2016). One lamb per ewe was euthanized through intravenous injection of Beuthanasia-D
Special (Merck Animal Health, Summit, NJ) containing 390 mg/mL sodium pentobarbital and 50
mg/mL phentoin based on BW, followed by exsanguination (Reed et al., 2014; Hoffman et al.,
2016). Lambs from ewes fed 100, 60, and 140% of NRC will be referred to as CON, RES and
OVER, respectively.

Sample Collection
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At necropsy, hind legs were removed, followed by removal of wool and muscle. Left
femur and tibia were collected, soaked in PBS, and transported to the laboratory for MSC
isolation. After 70% ethanol rinse, epiphyses of bones were removed. In the hood, bone marrow
was rinsed from bone shaft with -minimal essential media (MEM; ThermoFisher Scientific,
Waltham, MA) into a cell culture dish. This mixture was transferred to a falcon tube and
centrifuged for 3 minutes at 2,000 rpm. Red blood cells (RBC) were removed by addition of
ammonium chloride (Stem Cell Technologies, Vancouver, Canada), causing RBC lysis, and
passage through a 70 𝜇m filter. The isolated MSC were counted with a hemocytometer and
plated at 12 to 15 million cells per cell culture dish in maintenance media. The maintenance
media consisted of -MEM (ThermoFisher Scientific, Waltham, MA), 10% fetal bovine serum
(FBS; Atlanta Biologicals, Flowery Branch, Georgia), 0.5% Penicillin Streptomycin, and 0.25%
Fungizone. Media was changed every 2 to 3 d during incubation in 37oC and 5% CO2. Cells
were cultured to reach 70 to 80% adherent confluence. After centrifugation and media removal,
MSC were suspended in 1 mL cell guardian (B-Bridge, Cupertino, CA), transferred to cryovials,
and stored in liquid nitrogen for future studies.

Cell Culture
Mesenchymal stem cells (n = 6/treatment) in cryovials were removed from liquid
nitrogen storage, thawed, and transferred to falcon tubes. The falcon tubes were centrifuged for 3
minutes at 2,000 rpm and supernatant was removed. The MSC were re-suspended in -MEM
maintenance medium previously described and plated on cell culture dishes. The MSC were
cultured in -MEM maintenance medium at 37oC and 5% CO2. When the MSC reached 70 to
80% confluence, cell adherence to the dish was dissolved by adding a 50% trypsin, 50% PBS
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solution to the culture dishes for 3 minutes at 37oC and 5% CO2. The action of trypsin was
stopped with the addition of an equal quantity of -MEM maintenance medium. The MSC were
collected following scraping using a cell scraper and centrifugation for 3 minutes at 2,000 rpm.
After removal of supernatant, MSC were re-suspended in -MEM maintenance medium,
counted with a hemocytometer, and plated on Seahorse XFe24 cell culture plates at 30,000 cells
per well. Six animals were used per treatment group (n = 6/treatment) and there were two
technical replicates per animal. These culture plates were incubated for 48 h in 37 oC and 5%
CO2.

Glycolysis Stress Test Assay
On the day prior to the assay, the sensor cartridge was hydrated in Seahorse XF Calibrant
at 37oC and 0% CO2 overnight. On the morning of the assay, the assay medium was prepared.
Following addition of 2 mM glutamine (Sigma Aldrich, St. Louis, MO), the medium was
warmed to 37oC and pH adjusted to 7.4 with 0.1 N NaOH and sterile filtered. From the kit, one
vial each of glucose, oligomycin, and 2-DG was opened. The glucose, oligomycin, and 2-DG
vials were re-suspended with 3000 L, 720 L, and 3000 L of assay medium, respectively. The
solutions were pipetted up and down ten times, and the 2-DG solution was vortexed. The
injection ports were loaded using the constant volume method described in the manufacturer’s
protocol. The XFe24 cell culture plate was examined under the microscope to confirm
confluence. The -MEM maintenance medium was removed with a pipette and replaced with
prepared 37oC assay medium. The wells were rinsed with assay medium 2 times. The wells were
then filled with 525 L of assay medium, and the cell culture plate was incubated for one hour in
37oC and 0% CO2. The cell culture plate and sensor cartridge were loaded into the Seahorse
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Bioscience XFe24 Extracellular Flux Analyzer. Following a 15 to 30 minute calibration, the lid
of the sensor cartridge was removed and the assay was run. The assay was performed using
Wave software. The XFe24 analyzer automatically injected the wells subsequently with glucose
(to stimulate basal glycolysis), oligomycin (to inhibit ATP synthase and maximize glycolysis),
and 2-DG (to competitively bind hexokinase and inhibit glycolysis). The analyzer quantifies
glycolysis as a measure of extracellular acidification rate (ECAR) of the assay medium in the
wells, since protons are extruded during glycolysis.

Cell Mito Stress Test Assay
On the day prior to the assay, the sensor cartridge was hydrated in Seahorse XF Calibrant
at 37oC and 0% CO2 overnight. On the morning of the assay, the assay medium was prepared
and sterile filtered. Following addition of 1mM pyruvate (Sigma Aldrich, St. Louis, MO), 2 mM
glutamine (Sigma Aldrich, St. Louis, MO), and 10 mM glucose (Sigma Aldrich, St. Louis, MO),
the medium was warmed to 37oC and pH adjusted to 7.4 with 0.1 N NaOH. The foil pouch from
the assay kit was removed and the reagents were allowed to warm to room temperature in the
sealed pouch, for 15 minutes. The oligomycin, FCCP, and rotenone/antimycin A vials were then
removed and re-suspended with 630 L, 720 L, and 540 L of prepared assay medium,
respectively. The reagents were pipetted up and down ten times to solubilize the compounds. The
injection ports were loaded using the constant volume method described in the manufacturer’s
protocol. The XFe24 cell culture plate was examined under the microscope to confirm
confluence. The -MEM maintenance medium was removed with a pipette and replaced with
prepared 37oC assay medium. The wells were rinsed with assay medium 2 times. The wells were
then filled with 525 L of assay medium, and the cell culture plate was incubated for one hour in
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37oC and 0% CO2. Following a 15 to 30 minute calibration, the lid of the sensor cartridge was
removed and the assay was run. The assay was performed using Wave software. The XF e24
analyzer automatically injected the wells subsequently with oligomycin (to inhibit ATP synthase
and therefore OXPHOS), FCCP (to uncouple and therefore maximize OXPHOS), and
rotenone/antimycin A (to inhibit complexes I and III of the ETC and therefore shut down
OXPHOS). The analyzer quantifies OXPHOS as a measure of oxygen consumption rate (OCR)
of the assay medium in the wells, since oxygen is consumed during OXPHOS.

Data Normalization
Data were normalized for total DNA per well using the Macharey-Nagel NucleoSpin®
Tissue kits (Macharey-Nagel Inc., Bethlehem, PA). The procedure was followed according to the
manufacturer’s instructions.

Calculations
Glycolysis Stress Assay
After the ECAR measurements from the assay were normalized for total DNA, the
following calculations were performed in order to evaluate the various parameters associated
with glycolysis. These glycolytic parameters can be calculated from the changes in ECAR in
response to the various injections of compounds that either stimulated or inhibited glycolysis.
Refer to Figure 1 for the designation of measurement number.

Glycolysis: (maximum of ECAR measurements #4 - 6) minus (ECAR measurement #3)
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Glycolytic Reserve: (maximum of ECAR measurements #7 - 9) minus (maximum of ECAR
measurements #4 - 6)
Glycolytic Reserve Capacity: [(maximum ECAR of measurements #7 - 9) minus (ECAR
measurement #3)] divided by GLYCOLYSIS
Non-glucose-derived ECAR: minimum of ECAR measurements #10 - 12

Mito Stress Assay
After the OCR measurements from the assay were normalized for total DNA, the
following calculations were performed in order to evaluate the various parameters associated
with OXPHOS. These OXPHOS parameters can be calculated from the changes in OCR in
response to the various injections of compounds that either stimulated or inhibited the ETC.
Refer to Figure 2 for the designation of measurement number.

Non-mitochondria-derived OCR: minimum of OCR measurements #10 - 12
Basal Respiration: (OCR measurement #3) minus NON-MITO OCR
Proton Leak: (minimum of OCR measurements #4 - 6) minus NON-MITO OCR
ATP Production: BASAL RESP minus PROTON LEAK
Maximal Respiration: (maximum of OCR measurements #4 - 9) minus NON-MITO OCR
Spare Respiratory Capacity: MAX RESP minus BASAL RESP
(expressed as fold increase): MAX RESP divided by BASAL RESP
Coupling Efficiency: 100 multiplied by (ATP PROD divided by BASAL RESP)

Statistical Analysis
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Statistical analysis was performed using PROC MIXED in Statistical Analysis Software
version 9.2 (SAS Inst. Inc, Cary, NC). Least square means were used to make mean comparisons
when appropriate. Statistical significance was considered to be P < 0.05. Outlier analysis was
performed in SAS, and outliers were removed from both the glycolysis stress and cell mito stress
data sets. As a result, one OVER animal from the glyco stress test (n = 6, 6, and 5; CON, RES,
and OVER, respectively) and one RES animal from the cell mito stress test (n = 6, 5, and 6;
CON, RES, and OVER, respectively) were removed from the calculations and data analysis.
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RESULTS

Glycolysis Stress Test
ECAR increased in all treatment groups after MSC were injected with glucose, and
increased further after the injection of oligomycin (Figure 3). The injection of 2-DG decreased
ECAR in all treatment groups (Figure 3). There were no significant differences in basal
glycolysis, glycolytic reserve, non-glucose-derived ECAR, and glycolytic reserve capacity
between treatment groups (P ≥ 0.3; Figures 4A and 4B).

Mito Stress Test
In all treatment groups, OCR decreased with the injection of oligomycin, increased with
the injection of FCCP, and decreased again with the injection of rotenone and antimycin A
(Figure 5). Compared with CON, basal respiration decreased by 29% and 31% in RES and
OVER, respectively (127.4  7.5, 90.2  9.8, and 87.5  8.5 ρmol O2-1·minute-1·μg; CON, RES,
and OVER, respectively; P ≥ 0.004; Figure 6A). Additionally, ATP production was reduced 30%
and 36% in RES and OVER, respectively compared with CON (121.1  6.1, 84.9  11.1, and
77.7  6.4 ρmol O2-1·minute-1·μg; CON, RES, and OVER, respectively; P ≥ 0.001; Figure 6A).
Compared with CON, maximal respiration was reduced 39% and 55% in RES and OVER,
respectively (149.3  17.1, 90.6  23.8, and 67.9  10.1 ρmol O2-1·minute-1·μg; CON, RES, and
OVER, respectively; P ≥ 0.004; Figure 6A). Additionally, spare respiratory capacity was reduced
in OVER compared with CON, but was not different between RES and CON (21.9  10.8, 0.47
 15.1, and -19.6  9.2 ρmol O2-1·minute-1·μg; CON, RES, and OVER, respectively; P ≥ 0.02;
Figure 6A). Proton leak, non-mitochondria-derived OCR, spare respiratory capacity (expressed
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as a fold increase), and coupling efficiency were not different among treatment groups (P ≥ 0.07;
Figures 6A, 6B, 6C).
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DISCUSSION

The effects of poor maternal diet during gestation on the development of the offspring are
well documented (Oreffo et al., 2003; Wu et al., 2006; Lanham et al., 2010; Reed et al., 2014). In
general, the development of bone and muscle is restricted while the development of adipose is
increased in multiple species (Oreffo et al., 2003; Wu et al., 2006; Lanham et al., 2010; Reed et
al., 2014). Specific effects in bone include decreased bone density, reduced bone mineral
content, and reduced bone area (Oreffo et al., 2003). In muscle, Reed et al. (2014) found that
altered muscle development can be attributed in part to a decrease in muscle cross-sectional area
and Wu et al. (2006) noted that the proportion of muscle fiber types varies in relation to maternal
diet. These studies also found that carcass adiposity in the offspring is increased in both
restricted-fed and over-fed mothers, compared with control (Wu et al., 2006; Reed et al., 2014).
Despite this information, the mechanism(s) connecting poor maternal nutrition during gestation
to poor fetal growth and development are not established. There are most likely several
mechanisms, due to the complexity of growth and development.

Due to the common origin of bone, muscle, and adipose tissues, current research focuses
on the effects of poor maternal diet during gestation on MSC function (Oreffo et al., 2003; Pillai
et al., 2014). The restricted diet has been found to delay the normal proliferation and
differentiation of MSC, which are both required for proper development of bone, muscle, and
adipose (Oreffo et al., 2003). Similarly, our laboratory previously demonstrated that the
proliferation of the same MSC used in this study was reduced by 51% and 58% in RES and
OVER, respectively, compared with CON (P ≥ 0.03; Pillai et al., 2014). These proliferation data
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are evidence of cellular programming. Despite culture in a standard nutrient-rich medium, the
function of MSC from RES and OVER are still different from CON. Therefore, poor maternal
diet during gestation appears to permanently alter MSC function. The ‘predictive adaptive
response’ suggests that the purpose of in utero fetal programming is to maximize chances of
survival once the fetus is born into a nutrient-rich or nutrient-restricted environment (Lanham et
al., 2010). Therefore, the offspring of RES and OVER mothers could possibly be shifting
resources away from the development of muscle and bone in order to preserve resources for
processes more useful to survival, such as energy storage in adipose.

Fernandez-Twinn et al. (2010) found that malnutrition in utero can specifically alter
metabolic physiology in order to prioritize nutrients towards more vital organs at the expense of
other organs. Several studies have demonstrated that the metabolic state of a cell and its
subsequent proliferative ability are correlated (Shyh-Chang et al., 2013; Lyublinskaya et al.,
2015). For example, Pillai et al. (2014) found that the proliferation of MSC was reduced in RES
and OVER while our current study found that MSC from RES and OVER experienced reduced
basal respiration and ATP production. This suggests that poor maternal diet during gestation
results in a reduced metabolic state, which is correlated with reduced proliferative ability in
MSC. Shyh-Chang et al. (2013) found that metabolism is a key determinant of whether a cell
proliferates, differentiates, or remains quiescent. Therefore, the observed alterations in
metabolism have the potential to possibly affect the cell cycle of MSC, and either increase or
decrease proliferation. Additionally, the literature suggests that stem cell metabolism differs
from regular somatic cell metabolism (Shyh-Chang et al., 2013; Lyublinskaya et al., 2015).
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These undifferentiated, quiescent stem cells prefer what is known as a “slow-cycling”
state (Shyh-Chang et al., 2013). Therefore, MSC tend to rely more on glycolysis as opposed to
OXPHOS to meet energy needs (Shyh-Chang et al., 2013). Current studies have found that poor
maternal diet during gestation can alter MSC metabolism (Lyublinskaya et al., 2015). In our
study, we found that MSC from RES and OVER preferred a reduced metabolic state compared
with CON. Both MSC from RES and OVER experienced a reduction in basal respiration and
ATP production and no change in glycolysis. Therefore, MSC from RES and OVER are overall
less metabolically active than CON. Since stem cell metabolism is correlated with stem cell
niche, it is important to consider the role of oxygen.

Bone marrow-derived MSC, such as the ones used in our study, are suited for a lowoxygen niche that promotes the maintenance of the undifferentiated state (Ito et al., 2014).
However, the MSC used in the culture and assay conditions are no longer in this hypoxic
environment and therefore the increased oxygen availability should increase oxygen utilization
(Ito et al., 2014). mTOR is one such signaling pathway that up-regulates metabolism in response
to the sensing of high oxygen and nutrient availability (Ito et al., 2014). Therefore, it is expected
that cells maintain a greater metabolic state under increased oxygen availability. Under
normoxia, the MSC from RES, OVER, and CON all experienced comparable rates of glycolysis,
which is likely because oxygen is not involved in glycolysis. However, MSC from RES and
OVER experienced reduced reliance on mitochondrial ATP production, compared with CON.
This suggests that MSC from RES and OVER do not utilize as much oxygen for energy
production via OXPHOS as CON, under normoxic conditions. Considering the relationship
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between OXPHOS and cellular injury, this could possibly be a defense mechanism to avoid
cellular injury (Shyh-Chang et al., 2013).

Under normoxic conditions, MSC experience increased proliferative ability but at the
expense of increased senescence (Shyh-Chang et al., 2013). When proliferation is restricted,
stem cell longevity is extended through decreased aging, quiescence, and stem cell exhaustion
(Ito et al., 2014). We found that MSC from RES and OVER had both reduced proliferation and
reduced OXPHOS, compared with CON (Pillai et al., 2014). Oreffo et al. (2013) similarly found
that proliferation of MSC was reduced in protein-restricted ewes. Therefore, it is possible that
MSC from RES and OVER are programmed to limit OXPHOS in order to limit ROS and
preserve stem cell longevity, because the animal is preparing for birth into an anticipated
unfavorable environment. There is an important balance between proliferation (and therefore
increased metabolic activity) and stem cell longevity. Increased metabolic activity promotes
proliferation but can cause cellular injury, especially in stem cells, through ROS and oxidative
stress. However, preserving stem cell longevity through reducing metabolic activity can limit
proliferation. Alternatively, the observed differences in MSC metabolism could have been due to
changes in an oxygen-sensing pathway.

Hypoxia-inducible factors (HIF) regulate the ratio of glycolysis to OXPHOS in response
to the amount of environmental oxygen (Agathocleous et al., 2013; Burgess et al., 2014). HIF-1
is released during low oxygen conditions, and inhibits the TCA cycle by stimulating pyruvate
dehydrogenase kinase (PDK), which phosphorylates and inactivates pyruvate dehydrogenase
(PDH), an enzyme critical for the glycolysis to TCA cycle transition (Ochocki et al., 2013; Ito et
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al., 2014). Under the normoxic laboratory conditions, it would be expected that HIF is not
released, PDK is inactive, PDH is dephosphorylated and active, the TCA cycle continues, and
mitochondrial ATP production is increased. However, we found that ATP production was
reduced in MSC from RES and OVER, compared with CON. It is possible that the action of HIF,
or other oxygen-sensing pathways, is altered in MSC from RES and OVER, and this hypothesis
can be pursued further by studying the relative expression of HIF in these MSC.

In addition to this oxygen-sensing pathway, there are nutrient-sensing pathways that
regulate the metabolic activity in response to perceived energetic deficits. In our study, we found
that MSC from RES and OVER experienced a reduction in maximal respiration while only MSC
from OVER experienced a reduction in spare respiratory capacity, compared with CON. This
suggests that MSC from RES and OVER have a reduced ability to up-regulate ATP production
during energetic deficits. This could possibly suggest an alteration in one of the nutrient-sensing
pathways. Liver kinase B1 (LKB1) is a serine/threonine kinase that limits cell growth under low
energy conditions, which are sensed as an increased AMP/ATP ratio (Agathocleous et al., 2013;
Ito et al., 2014). The pathway works through the phosphorylation and activation of AMPK,
which inhibits mTORC1 (Agathocleous et al., 2013; Ito et al., 2014). As previously described,
mTOR is a proliferation pathway that is stimulated when high nutrient conditions are sensed. It
appears that the metabolisms of MSC from RES and OVER are not responding appropriately to
energetic deficits. These studies of maternal-fetal metabolic physiology have demonstrated that
in utero conditions, such as poor maternal diet, can lead to permanent alterations in metabolism.
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The changes in the metabolic profile of MSC observed in our study can potentially lead
to the development of whole body metabolic dysfunction, and associated metabolic diseases. Wu
et al. (2006) found that poor maternal diet can lead to metabolic diseases, such as insulin
resistance, obesity, oxidative stress, and mitochondrial dysfunction in sheep. Some in utero
conditions, such as poor maternal diet, appear to have permanent, irreversible changes to normal
fetal physiology. Barker and Hales proposed an idea that ‘fetal metabolic programming’ is a risk
factor for the development of chronic metabolic disorders (Hales et al., 2001). Therefore,
continued research in the field of fetal metabolic physiology remains an important aspect of
maternal nutritional studies.

In conclusion, data in our study provided some insight into the complex relationship
between fetal metabolic physiology, specifically in MSC, and maternal diet during gestation.
However, further studies are needed to determine the role of altered MSC metabolism as the
mechanism connecting poor maternal diet to poor fetal growth and development. In order to do
so, more metabolic parameters than just ECAR and OCR need to be evaluated. Future directions
should focus on gene studies (mTOR pathway, LKB1 pathway, FOXO, HIF), ROS levels, and
the NAD/NADH ratio. From our study, we can say that maternal over- and under-nutrition
during gestation reduce the basal metabolic state of offspring MSC, and the ability of these cells
to up-regulate ATP production during energetic deficits. The altered MSC metabolism could
possibly contribute to impaired muscle, bone, and adipose growth and maintenance in offspring.

\
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FIGURES

Figure 1. Model Output for Glycolysis Stress Assay. Extracellular acidification rate (ECAR)
measured after cells subsequently exposed to glucose, oligomycin, and 2-deoxy-glucose (2-DG).
ECAR values are negligible, as this figure is a model for data calculations. Measurements will
subsequently be referred to as number 1, 2, 3, etc.
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Figure 2. Model Output for Cell Mito Stress Assay. Oxygen consumption rate (OCR)
measured after cells subsequently exposed to oligomycin, FCCP, and Antimycin A & Rotenone.
OCR values are negligible, as this figure is a model for data calculations. Measurements will
subsequently be referred to as number 1, 2, 3, etc.
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Figure 3. Glycolysis Stress Test. Extracellular acidification rate (ECAR) measured after MSC
were subsequently exposed to glucose (to stimulate basal glycolysis), oligomycin (to inhibit ATP
synthase and maximize glycolysis), and 2-deoxy-glucose (to competitively bind hexokinase and
inhibit glycolysis). n = 6/treatment.
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Figure 4. Glycolysis Stress Test Results. (A) Calculations of glycolysis (GLYCOLYSIS),
glycolytic reserve (GLYCO RES), and non-glucose-derived ECAR (NON-GLUCOSE ECAR) in
MSC. n = 6/treatment. Data are presented as mean  SE. P > 0.05 among treatment groups. (B)
Glycolytic reserve capacity (GLYCO RES CAP) expressed as a function of fold increase. n =
6/treatment. Data are presented as mean  SE. P > 0.05.
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Figure 5. Cell Mito Stress Test. Oxygen consumption rate (OCR) measured after MSC
subsequently exposed to oligomycin (to inhibit ATP synthase and therefore oxidative
phosphorylation), FCCP (to uncouple and therefore maximize oxidative phosphorylation), and
Antimycin A & Rotenone (to inhibit complexes I and III of the electron transport chain and
therefore shut down oxidative phosphorylation). n = 6/treatment.
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Figure 6. Cell Mito Stress Test Results. (A) Calculations of basal respiration (BASAL RESP),
proton leak (PROTON LEAK), ATP production (ATP PROD), maximal respiration (MAX
RESP), spare respiratory capacity (SPARE RESP CAP), and non-mitochondria-derived OCR
(NON-MITO OCR) in MSC. n = 6/treatment. Data are presented as mean  SE. *P < 0.05
among treatment groups. (B) Spare respiratory capacity expressed as a function of fold increase.
n = 6/treatment. Data are presented as mean  SE. P > 0.05. (C) Calculation of coupling
efficiency in MSC. n = 6/treatment. Data are presented as mean  SE. P > 0.05.

50

REFERENCES

Agathocleous, M., W. A. Harris. 2013. Metabolism in physiological cell proliferation and
differentiation.

Trends

in

Cell

Biology.

Vol.

23,

No.

10,

484-492.

doi:

10.1016/j.tcb.2013.05.004
Bhat, A. H., K. B. Dar, S. Anees, M. A. Zargar, A. Masood, M. A. Sofi, S. A. Ganie. 2015.
Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a
mechanistic

insight.

Biomedicine

and

Pharmacotherapy.

74:

101-110.

doi:

10.1016/j.biopha.2015.07.025
Burgess, R. J., M. Agathocleous, S. J. Morrison. 2014. Metabolic regulation of stem cell
function. Journal of Internal Medicine. 276: 12-24. doi: 10.1111/joim.12247
Chiaratti, M. R., S. Malik, A. Diot, E. Rapa, L. Macleod, K. Morten, M. Vatish, R. Boyd, J.
Poulton. 2015. Is Placental Mitochondrial Function a Regulator that Matches Fetal and
Placental Growth to Maternal Nutrient Intake in the Mouse? PLoS ONE. 10(7):
e0130631. doi: 10.1371/journal.pone.0130631.
Estrada, J. C., C. Albo, A. Benguría, A. Dopazo, P. López-Romero, L. Carrera-Quintanar, E.
Roche, E. P. Clemente, J. A. Enríquez, A Bernad, E. Samper. 2012. Culture of human
Mesenchymal stem cells at low oxygen tension improves growth and genetic stability by
activating

glycolysis.

Cell

Death

and

Differentiation.

19:

743-755.

doi:

10.1038/cdd.2011. 172.
Fernandez-Twinn, D. S., S. E. Ozanne. 2010. Early life nutrition and metabolic programming.
Annals of the New York Academy of Sciences. 1212: 78-96. doi: 10.1111/j.17496632.2010.05798.x

51

Fillmore, N., A. Huqi, J. S. Jaswal, J. Mori, R. Paulin, A. Haromy, A. Onay-Besikci, L. Ionescu,
B. Thébaud, E. Michelakis, G. D. Lopaschuk. 2015. Effect of Fatty Acids on Human
Bone Marrow Mesenchymal Stem Cell Energy Metabolism and Survival. PLOS ONE.
10(3): e0120257. doi: 10.1371/journal.pone.0120257
Gallardo, J. M., J. Gómez-López, P. Medina-Bravo, F. Juárez-Sánchez, A. Contreras-Ramos, M.
Galicia-Esquivel, R. Sánchez-Urbina, M. Klünder-Klünder. 2015. Maternal Obesity
Increases Oxidative Stress in the Newborn. Obesity Biology and Integrated Physiology.
23: 1650-1654. doi: 10.1002/oby.21159.
Hales, C. N., D. J. P. Barker. 2001. The thrifty phenotype hypothesis – Type 2 diabetes. British
Medical Bulletin. 60 (1): 5-20. doi: 10.1093/bmb/60.1.5
Hoffman, M. L., K. N. Peck, M. E. Forella, A. R. Fox, K. E. Govoni, S. A. Zinn. 2016. The
effects of poor maternal nutrition during gestation on postnatal growth and development
of lambs. Journal of Animal Science. 94: 789-799. doi: 10.2527/jas2015-9933.
Igosheva, N., A. Y. Abramov, L. Poston, J. J. Eckert, T. P. Fleming, M. R. Duchen, J.
McConnell. 2010. Maternal Diet-Induced Obesity Alters Mitochondrial Activity and
Redox Status in Mouse Oocytes and Zygotes. PLoS ONE. 5(4): e10074. doi:
10.1371/journal.pone.0010074.
Ito, K., T. Suda. 2014. Metabolic requirements for the maintenance of self-renewing stem cells.
Nature Reviews: Molecular Cell Biology. 15: 243-256. doi: 10.1038/nrm3772
Lanham, S. A., C. Roberts, T. Hollingworth, R. Sreekumar, M. M. Elahi, F. R. Cagampang, M.
A. Hanson, R. O. C. Oreffo. 2010. Maternal high-fat diet: effects on offspring bone
structure. Osteoporosis International. 21:1703-1714. doi: 10.1007/s00198-009-1118-4

52

Lawrence, T., V. Fowler, J. Novakofski. 2012. Growth of Farm Animals. 3rd ed. CABI,
Cambridge, MA. p 33-35, 45, 51, 61-63, 83.
Lyublinskaya O. G., Y. G. Borisov, N. A. Pugovkina, I. S. Smirnova, J. V. Obidina, J. S.
Ivanova, V. V. Zenin, A. N. Shatrova, A. V. Borodkina, N. D. Aksenov, V. I. Zemelko,
E. B. Burova, M. V. Puzanov, N. N. Nikolsky. 2015. Reactive Oxygen Species Are
Required for Human Mesenchymal Stem Cells to Initiate Proliferation after the Quiescent
Exit.

Oxidative

Medicine

and

Cellular

Longevity.

2015(502105).

doi:

10.1155/2015/502105
Ochocki, J. D., M. C. Simon. 2013. Nutrient-sensing pathways and metabolic regulation in stem
cells. The Journal of Cell Biology. Vol. 203, No. 1, 23-33. doi: 10.1083/jcb.201303110
Oreffo, R. O. C., B. Lashbrooke, H. I. Roach, N. M. P. Clarke, C. Cooper. 2003. Maternal
protein deficiency affects Mesenchymal stem cell activity in the developing offspring.
Bone. 33(2003): 100-107. doi: 10.1016/S8756-3282(03)00166-2
Pillai, S. M., M. L. Hoffman, K. N. Peck, E. V. Valley, T. D. Crenshaw, S. A. Zinn, & K. E.
Govoni. 2014. Poor maternal nutrition during gestation reduces mesenchymal stem cell
(MSC) proliferation in offspring. Journal of Animal Science. 92(E-Supplement 2): 589.
(Abstr.)
Ramalingam M., Z. Haidar, S. Ramakrishna, H. Kobayashi, Y. Haikel. 2012. Integrated
Biomaterials in Tissue Engineering. John Wiley & Sons, Hoboken, NJ. p 137-164.
Reed, S. A., J. S. Raja, M. L. Hoffman, S. A. Zinn, K. E. Govoni. 2014. Poor maternal nutrition
inhibits muscle development in ovine offspring. Journal of Animal Science and
Biotechnology. 5:43. doi: 10.1186/2049-1891-5-43

53

Shyh-Chang, N., G. Q. Daley, L. C. Cantley. 2013. Stem cell metabolism in tissue development
and aging. Development. 140: 2535-2547. doi: 10.1242/dev.091777
Tamashiro, K.L.K., T.H. Morgan. 2010. Perinatal environment and its influence on metabolic
programming of offspring. Physiology & Behavior.100: 560-566. doi:
10.1016/j.physbeh.2010.04.008
Vonnahme, K. A., C. O. Lemley, J. S. Caton, A. M. Meyer. 2015. Review: Impacts of Maternal
Nutrition on Vascularity of Nutrient Transferring Tissues during Gestation and Lactation.
Nutrients. 7: 3497-3523. doi: 10.3390/nu7053497.
Wu, G., F. W. Bazer, J. M. Wallace, T. E. Spencer. 2006. BOARD-INVITED REVIEW:
Intrauterine Growth Retardation: Implications for the Animal Sciences. Journal of
Animal Science. 84: 2316-2337. doi: 10.2527/jas.2006-156.

54

